ExploreWatchlistsPricing
  1. US-listed companies
  2. BRAINSTORM CELL THERAPEUTICS INC.
  3. Financials
  4. Total liabilities

BRAINSTORM CELL THERAPEUTICS INC. (BCLI)

Market cap
$11.03M
P/E ratio
SummaryFinancials
Period EndTotal liabilities (Million USD)YoY (%)
Dec 31, 202511+14.70%
Dec 31, 202410+5.85%
Dec 31, 20239-20.93%
Dec 31, 202211+15.41%
Dec 31, 202110-37.10%
Dec 31, 202016-15.79%
Dec 31, 201919+201.95%
Dec 31, 20186+12.07%
Dec 31, 20176+541.55%
Dec 31, 20161-70.73%
Dec 31, 20153-8.78%
Dec 31, 20143+62.86%
Dec 31, 20132+58.20%
Dec 31, 20111

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat